Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALKACITRAT for Functional Dyspepsia
2024-512688-30-00Phase 4Authorised
- Sponsor
- Uni-Pharma
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in functional dyspepsia (FD) comparing ALKACITRAT with Placebo (2 arms). Planned start Jul 2024; status: authorised.
02
Drugs
citric acid + sodium citrate
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on 2024-512688-30-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-512688-30-00.